✦ LIBER ✦

Gefitinib: phase II and III results in advanced non-small cell lung cancer

✍ Scribed by Karen Kelly; Steven Averbuch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib in advanced non-small cell lun

✍ R. Sharma; M. Boyer; S. Clarke; M. Millward 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Gefitinib for refractory advanced non-sm

✍ Hisashi Moriguchi; Tae-You Kim; Chifumi Sato 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 39 KB

Gefitinib for refractory advanced non-sm

✍ Junji Tsurutani; Marc Ballas; Seth M Steinberg; Valgardur Egilsson; Phillip A De 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 31 KB

Gefitinib or docetaxel in advanced non-s

✍ Michael Cullen; Nicholas Thatcher 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 283 KB

Phase II trial of gefitinib in pretreate

✍ Jing Deng, Wei Jia Fang, Xiao Chen Zhang, Dong Ping Wu, Hong Ming Fang, Jing Che 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 178 KB

Erlotinib in advanced non-small-cell lun

✍ Zheng-Tao Zhou; Xin-Hua Xu; Qing Wei; Ming-qian Lu; Jie Wang; Cai-Hong Wen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 262 KB